248 related articles for article (PubMed ID: 24708874)
1. Targeting xCT, a cystine-glutamate transporter induces apoptosis and tumor regression for KSHV/HIV-associated lymphoma.
Dai L; Cao Y; Chen Y; Parsons C; Qin Z
J Hematol Oncol; 2014 Apr; 7():30. PubMed ID: 24708874
[TBL] [Abstract][Full Text] [Related]
2. Genomic analysis of xCT-mediated regulatory network: Identification of novel targets against AIDS-associated lymphoma.
Dai L; Cao Y; Chen Y; Kaleeba JA; Zabaleta J; Qin Z
Oncotarget; 2015 May; 6(14):12710-22. PubMed ID: 25860939
[TBL] [Abstract][Full Text] [Related]
3. Genomic analysis of xCT-regulatory network in KSHV + primary effusion lymphomas.
Qin Z; Cao Y; Dai L
Genom Data; 2016 Jun; 8():16-7. PubMed ID: 27081633
[TBL] [Abstract][Full Text] [Related]
4. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of xCT induces up-regulation of 14-3-3beta in Kaposi's sarcoma.
Zeng Y; Li Y; Chen RS; He X; Yang L; Li W
Biosci Rep; 2010 Mar; 30(4):277-83. PubMed ID: 20100173
[TBL] [Abstract][Full Text] [Related]
6. Systematic analysis of a xenograft mice model for KSHV+ primary effusion lymphoma (PEL).
Dai L; Trillo-Tinoco J; Bai L; Kang B; Xu Z; Wen X; Del Valle L; Qin Z
PLoS One; 2014; 9(2):e90349. PubMed ID: 24587336
[TBL] [Abstract][Full Text] [Related]
7. Nm23-H1 induces apoptosis in primary effusion lymphoma cells via inhibition of NF-κB signaling through interaction with oncogenic latent protein vFLIP K13 of Kaposi's sarcoma-associated herpes virus.
Mohanty S; Kumar A; Das P; Sahu SK; Mukherjee R; Ramachandranpillai R; Nair SS; Choudhuri T
Cell Oncol (Dordr); 2022 Oct; 45(5):967-989. PubMed ID: 35964258
[TBL] [Abstract][Full Text] [Related]
8. p53 reactivation kills KSHV lymphomas efficiently in vitro and in vivo: new hope for treating aggressive viral lymphomas.
Sarek G; Ojala PM
Cell Cycle; 2007 Sep; 6(18):2205-9. PubMed ID: 17890905
[TBL] [Abstract][Full Text] [Related]
9. In primary effusion lymphoma cells, MYB transcriptional repression is associated with v-FLIP expression during latent KSHV infection while both v-FLIP and v-GPCR become involved during the lytic cycle.
Lacoste V; Nicot C; Gessain A; Valensi F; Gabarre J; Matta H; Chaudhary PM; Mahieux R
Br J Haematol; 2007 Aug; 138(4):487-501. PubMed ID: 17659053
[TBL] [Abstract][Full Text] [Related]
10. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma-associated herpesvirus fusion-entry receptor: cystine transporter xCT.
Kaleeba JA; Berger EA
Science; 2006 Mar; 311(5769):1921-4. PubMed ID: 16574866
[TBL] [Abstract][Full Text] [Related]
12. Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression.
Dai L; Trillo-Tinoco J; Bai A; Chen Y; Bielawski J; Del Valle L; Smith CD; Ochoa AC; Qin Z; Parsons C
Oncotarget; 2015 Sep; 6(27):24246-60. PubMed ID: 26327294
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress.
Qin Z; Freitas E; Sullivan R; Mohan S; Bacelieri R; Branch D; Romano M; Kearney P; Oates J; Plaisance K; Renne R; Kaleeba J; Parsons C
PLoS Pathog; 2010 Jan; 6(1):e1000742. PubMed ID: 20126446
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7.
Kim YJ; Kim Y; Kumar A; Kim CW; Toth Z; Cho NH; Lee HR
PLoS Pathog; 2021 Jan; 17(1):e1009179. PubMed ID: 33471866
[TBL] [Abstract][Full Text] [Related]
15. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
Smith CG; Kharkwal H; Wilson DW
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor.
Lan K; Murakami M; Bajaj B; Kaul R; He Z; Gan R; Feldman M; Robertson ES
Cancer Biol Ther; 2009 Nov; 8(22):2136-43. PubMed ID: 19783901
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ.
Zhang L; Zhu C; Guo Y; Wei F; Lu J; Qin J; Banerjee S; Wang J; Shang H; Verma SC; Yuan Z; Robertson ES; Cai Q
J Virol; 2014 Jun; 88(12):6873-84. PubMed ID: 24696491
[TBL] [Abstract][Full Text] [Related]
18. KSHV viral cyclin binds to p27KIP1 in primary effusion lymphomas.
Järviluoma A; Koopal S; Räsänen S; Mäkelä TP; Ojala PM
Blood; 2004 Nov; 104(10):3349-54. PubMed ID: 15271792
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of primary effusion lymphoma engraftment in SCID mice by morpholino oligomers against early lytic genes of Kaposi's sarcoma-associated herpesvirus.
Zhang YJ; Patel D; Nan Y; Fan S
Antivir Ther; 2011; 16(5):657-66. PubMed ID: 21817187
[TBL] [Abstract][Full Text] [Related]
20. Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma.
Qin Z; Dai L; Trillo-Tinoco J; Senkal C; Wang W; Reske T; Bonstaff K; Del Valle L; Rodriguez P; Flemington E; Voelkel-Johnson C; Smith CD; Ogretmen B; Parsons C
Mol Cancer Ther; 2014 Jan; 13(1):154-64. PubMed ID: 24140934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
